Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation

被引:94
作者
Curtis, MJ
机构
[1] Kings Coll, Cardiovasc Res Labs, Vasc Biol Res Ctr, Cardiovasc IRG, London SW3 6LX, England
[2] Kings Coll, Pharmacol Grp, London SW3 6LX, England
基金
英国惠康基金;
关键词
antifibrillatory drugs; arrhythmia models; global ischaemia; ischaemia; Langendorff preparation; sudden cardiac death; ventricular fibrillation; working heart preparation;
D O I
10.1016/S0008-6363(98)00083-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The isolated perfused heart has been used increasingly during the last decade as a model for identifying actions of drugs on ventricular fibrillation (VF) induced by myocardial ischaemia. In addition, it has been used to explore the mechanisms responsible for the initiation and maintenance of VF, the concept of endogenous myocardial protection and the phenomenon of preconditioning. This article is a review of the available data (effects of drugs, sources of variation, comparison with other models and man, etc.) and an attempt to evaluate the possible clinical relevance. For several reasons, it is not possible to make a precise judgement on the absolute value of the model in terms of its ability to accurately predict the effectiveness of drugs in the prevention of sudden cardiac death, the main reason being the lack of a positive control, i.e. a drug with proven effectiveness against sudden cardiac death caused by VF in man. Nevertheless, the means by which one may reliably and reproducibly generate ischaemia-induced VF in different isolated heart preparations, and the factors (such as species, heart rate, perfusion constituents and involved zone size) that determine the incidence of VF are now well documented. Careful selection of species and experimental conditions permits the isolated heart of smaller inexpensive animals to function as a first line model for detecting anti-VF activity of probable relevance to phase 1 arrhythmogenesis (i.e., arrhythmogenesis during the first 30 min of ischaemia). In view of the absence of a clinical template from which to evaluate how well it predicts drug effectiveness in man, this model's clinical relevance, like that of all other preparations and models, can yet be neither accepted nor dismissed. Recent publication patterns suggest an increasing use of the model. Therefore, recommendations are made to facilitate its effective use. (C) 1998 Elsevier Science BN. All rights reserved.
引用
收藏
页码:194 / 215
页数:22
相关论文
共 104 条
[41]  
Friedrichs, 1996, J Cardiovasc Pharmacol Ther, V1, P313
[42]   Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation [J].
Friedrichs, GS ;
Abreu, JN ;
Driscoll, EM ;
Borlak, J ;
Lucchesi, BR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 (01) :56-66
[43]   R56865, A POTENT NEW ANTIARRHYTHMIC AGENT, EFFECTIVE DURING ISCHEMIA AND REPERFUSION IN THE RAT-HEART [J].
GARNER, JA ;
HEARSE, DJ ;
BERNIER, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (03) :468-479
[44]  
Gilman JK, 1997, J INTENSIVE CARE MED, V12, P1
[45]  
Gunn JA, 1913, HEART-J STUD CIRC, V5, P1
[46]  
GWILT M, 1992, EUR J PHARMACOL, V220, P231
[48]   INJECTION INTO PERICARDIAL SAC AND LIGATION OF CORONARY ARTERY OF THE RAT [J].
HEIMBURGER, RF .
ARCHIVES OF SURGERY, 1946, 52 (06) :677-689
[49]   FLOW OF INJURY CURRENT AND PATTERNS OF EXCITATION DURING EARLY VENTRICULAR ARRHYTHMIAS IN ACUTE REGIONAL MYOCARDIAL ISCHEMIA IN ISOLATED PORCINE AND CANINE HEARTS - EVIDENCE FOR 2 DIFFERENT ARRHYTHMOGENIC MECHANISMS [J].
JANSE, MJ ;
VANCAPELLE, FJL ;
MORSINK, H ;
KLEBER, AG ;
WILMSSCHOPMAN, F ;
CARDINAL, R ;
DALNONCOURT, CN ;
DURRER, D .
CIRCULATION RESEARCH, 1980, 47 (02) :151-165
[50]  
JANSE MJ, 1991, HEART CARDIOVASCULAR, P2055